Skip to content

RNAATRIUM THERAPEUTICS INC

CUSIP 04965N104 · common stock

1 tracked investor held ATRIUM THERAPEUTICS INC (RNA) at the end of Q3 2026, worth $2.2M. The largest holder was Adar1 Capital Management, with 0.1% of its portfolio.

Holders · Q3 2026
1
New holders
0
Value held
$2.2M
Quarter-end price (est.)
$8.28

Investors holding RNA · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.09%267,586$2.2MADD+363.9%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026100$2.2M$8.28
Q2 2026102$775.9K$13.45
Q1 2026330$12.5M$13.37